Award recordCONTRACT

MCKESSON PLASMA AND BIOLOGICS LLC

PIID VA26017P0102· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $185,814 net obligations· UEI M986PPZNJ8M8· TN

Description

DRUG: PRIVIGEN 10%, 5, 10&20 GRAM

First action · last action
2016-10-27 · 2016-12-19
Transactions
2
First transaction's obligation
$170,940
Base + all options value (sum of deltas)
$185,814
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$185,814$0Base award · 2016-10-27 · this action $170,940 · running total $170,940Modification P00001 · 2016-12-19 · this action $14,874 · running total $185,814
  • Base2016-10-27+$170,940= $170,940
  • Mod P000012016-12-19+$14,874= $185,814
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-27+$170,940$170,940DRUG: PRIVIGEN 10%, 5, 10&20 GRAM
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-12-19+$14,874$185,814DRUG: PRIVIGEN 10%, 5, 10&20 GRAM

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M986PPZNJ8M8)

AwardOffice · PSC / listingNet obligationsFY
36C26026P0671260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$18,262FY2026
36C24826P1019248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$16,333FY2026
36C26226P1217262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$16,333FY2026
36C24225P0537242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C25024P0468250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$25,200FY2024
36C25723P0156257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$3,434FY2023

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026
36C26026F0294BIOCRYST PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$151,465FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26017P0102_3600_-NONE-_-NONE- · retrieved 2026-09-26.